Share this
5 Trends in Biotech Dealmaking To Watch in 2021
January 15, 2021
Forbius Agrees to Sell to Bristol Myers Squibb
August 25, 2020
New Leadership for Cooley Life Sciences
July 17, 2020
Legal 500 US 2020 Highlights Cooley
June 24, 2020
Chambers USA 2020 Recognizes Cooley Lawyers + Practices
May 13, 2020
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
March 2, 2020
Best Lawyers 2020 – Cooley
November 18, 2019
IAM Recognizes 17 Cooley Lawyers as Patent Standouts
August 23, 2018
Best Lawyers 2019 – Cooley
August 16, 2018
Vir Acquires Humabs BioMed and Enters Six Strategic Partnerships
January 10, 2018
Jazz Pharmaceuticals Strikes Strategic Collaboration and Option Agreement with ImmunoGen
September 12, 2017
Best Lawyers 2018 – Cooley
August 16, 2017
miRagen Therapeutics’ Merger with Signal Genetics
November 2, 2016
Myovant Raises $218 Million in Largest Biotech IPO of Year
October 31, 2016
Best Lawyers 2017 – Cooley
August 15, 2016
Jazz Pharmaceuticals to Acquire Celator for $1.5 Billion
June 1, 2016
Bristol-Myers Squibb Enters Into Exclusive Worldwide License and Collaboration Agreement With Five Prime Therapeutics for Colony Stimulating Factor 1 Receptor (CSF1R) Antibody Program
October 15, 2015
Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin
August 24, 2015
Best Lawyers 2016 – Cooley
August 18, 2015
Axovant Completes $362 Million IPO
June 16, 2015
OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals
January 14, 2015
NewLink Genetics Signs $1 Billion Deal with Genentech for Cancer Drug Research and Development
October 22, 2014
Best Lawyers 2015 – Cooley
August 18, 2014
Cooley Advises Alder Biopharmaceuticals on Initial Public Offering
May 14, 2014
Cooley Advises Jazz Pharmaceuticals in Acquisition of ADX-N05
January 23, 2014
Numerous Cooley Attorneys Recognized in Best Lawyers 2014
August 15, 2013
Cooley Represents BioMarin in $10 Million Acquisition of Zacharon
January 9, 2013
Cooley Recognized as Elite Top-25 Law Firm (Financial Times)
December 4, 2012
Cooley Recognized as Elite Top-25 Law Firm by Financial Times
95 Cooley Attorneys Recognized in Best Lawyers
September 19, 2012
Cooley Advises Jazz Pharmaceuticals in Pending Acquisition of EUSA Pharma for up to $700 Million
April 26, 2012
Draft Biosimilars Guidances Released by Food and Drug Administration
February 16, 2012